Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
07 December 2023 - 5:06AM
Business Wire
- With more than 10 years of pioneering CGM market leadership in
AID integration, Dexcom is the most studied CGM brand with AID
capabilities and the clear choice for powering AID systems3,4
- The clinically meaningful health outcomes that result from
using the t:slim X2 insulin pump with Control-IQ technology are
proven only when the system is connected to Dexcom CGM
technology5
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time
continuous glucose monitoring for people with diabetes, announced
today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
connects with the t:slim X2™ insulin pump by Tandem Diabetes Care
in the United States, marking the first AID integration with the
Dexcom G7 CGM, the world’s most accurate1,2 CGM system.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231206143334/en/
Dexcom G7 CGM now connects with the
t:slim X2™ insulin pump by Tandem Diabetes Care in the U.S. (Photo:
Business Wire)
“There’s a reason Dexcom is the undisputed leader in CGM
connectivity and the clear choice for AID systems,” said Jake
Leach, executive vice president and chief operating officer at
Dexcom. “We pioneered industry-leading CGM connectivity more than a
decade ago and are the only CGM company to have safely powered AID
systems for more than 1 million patient years of cumulative use.
The clinically meaningful health outcomes that result from using
the t:slim X2 insulin pump with Control-IQ technology are proven
only when the system is connected to Dexcom CGM technology.”
Further solidifying Dexcom as the most studied CGM brand with
AID capabilities, new results from the COMISAIR seven-year follow
up – the longest prospective real-world CGM study ever conducted –
showed significant and continued reduction of HbA1c as well as a
lower risk of the development or progression of diabetic
retinopathy associated with the use of real-time CGM by people with
Type 1 diabetes.6 Additionally, the COMISAIR seven-year follow up
demonstrated further substantial reduction in HbA1c when Dexcom CGM
is connected to the Tandem t:slim X2 insulin pump with Control-IQ
technology. 6
“When AID systems are used in conjunction with real-time CGM,
people with diabetes experience more time in range, fewer
incidences of hypoglycemia and greater peace of mind,” said Dr.
Nicholas Argento, MD FACE. “As both a user and prescriber of these
connected systems, I’ve seen the positive impacts this technology
has on the health and overall wellbeing of people managing
diabetes, which is reaffirmed by a growing body of clinical
evidence.”
Dexcom G7 is the smallest, most accurate1,2 CGM system currently
connected to the t:slim X2 insulin pump. It is also the fastest CGM
connected to the t:slim X2 pump with a 30-minute sensor warmup,*
and along with Dexcom G6, are the only CGM systems with a
predictive urgent low soon alert and no fingersticks† required from
day one. Dexcom G7 users can also share glucose data with loved
ones and care teams in real time through industry-leading remote
monitoring capabilities.‡
Tandem will email instructions to all in-warranty t:slim X2
users in the United States to offer the option to add the new
feature free of charge via remote software update. Tandem t:slim X2
pumps pre-loaded with Dexcom G7 integration are now shipping to new
customers. Starting today, Dexcom G7 sensors compatible with the
t:slim X2 pump are available through Durable Medical Equipment
(DME) distributors, with pharmacy availability launching in early
January 2024.
To learn more and to get started with Dexcom G7 and the
Tandem t:slim X2 insulin pump today, visit
Dexcom.com/tandem.
The launch of Dexcom G7 and the Tandem t:slim X2 insulin pump
further strengthens Dexcom’s position as the world’s most connected
CGM.4 With more than 60 connected partners worldwide, Dexcom is
committed to providing users with choice and flexibility when it
comes to how they view their glucose data and deliver insulin.§ In
the U.S., Dexcom CGM is also integrated with the Omnipod® 5
Automated Insulin Delivery System; digital health apps including
Glooko, Happy Bob and Sugarmate, in addition to popular lifestyle
devices from Apple and Garmin.
Dexcom G7 and t:slim X2 insulin pump connectivity is expected to
launch in additional countries outside the U.S. in early 2024.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health
through innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, Calif., and with operations across
Europe and select parts of Asia/Oceania, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom works to simplify and
improve diabetes management around the world. For more information
about Dexcom CGM, visit www.dexcom.com.
*Dexcom G7 can complete warmup within 30 minutes, whereas other
CGM brands require up to an hour or longer. †If your glucose alerts
and readings from Dexcom G7 do not match symptoms or expectations,
use a blood glucose meter to make diabetes treatment decisions.
‡Separate Follow app and internet connection required. §Reference
www.dexcom.com/integrate.
1 U.S. Food and Drug Administration, 510(k) Substantial
Equivalence Determination Decision Summary, K213919. Published
December 7, 2022.
https://www.accessdata.fda.gov/cdrh_docs/reviews/K213919.pdf. 2
U.S. Food and Drug Administration, 510(k) Substantial Equivalence
Determination Decision Summary, K222447. Published March 3, 2023.
https://www.accessdata.fda.gov/cdrh_docs/reviews/K222447.pdf. 3
Peacock S, et al. Diabetes Ther. 2023;14(5):839-855. 4 Dexcom, data
on file, 2023. 5 Brown SA, et al. N Engl J Med.
2019;381(18):1707-1717. 6 Šoupal, J. Presented at EASD 2023,
Hamburg, Germany. October 2, 2023.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231206143334/en/
Media Contact James McIntosh
619-884-2118 james.mcintosh@dexcom.com
Investor Contact Sean
Christensen 858-203-6657 sean.christensen@dexcom.com
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2024 to May 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From May 2023 to May 2024